{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:16:54Z","timestamp":1791155814437,"version":"4.1.0"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>SH3-binding protein 2 (3BP2) is a cytoplasmic adaptor protein that acts as a positive regulator in mast cell Fc\u03b5RI\u2013dependent signaling. The KIT receptor whose ligand is the stem cell factor is necessary for mast cell development, proliferation, and survival as well as for optimal IgE-dependent signal. Activating mutations in KIT have been associated with several diseases including mastocytosis. In the present work, we found that 3BP2 silencing impairs KIT signaling pathways, thus affecting phosphoinositide 3-kinase and MAPK pathways in human mast cells (huMCs) from HMC-1, LAD2 (huMC lines), and CD34+-derived mast cells. Unexpectedly, silencing of 3BP2 reduces KIT expression in normal huMCs as well as in HMC-1 cells where KIT is mutated, thus increasing cellular apoptosis and caspase-3\/7 activity. 3BP2 silencing reduces KIT transcription expression levels. Interestingly, 3BP2 silencing decreased microphthalmia-associated transcription factor (MITF) expression, a transcription factor involved in KIT expression. Reconstitution of 3BP2 in knockdown cells leads to reversal of KIT expression as well as survival phenotype. Accordingly MITF reconstitution enhances KIT expression levels in 3BP2-silenced cells. Moreover, downregulation of KIT expression by miRNA-221 overexpression or the proteasome inhibitor bortezomib also reduced 3BP2 and MITF expression. Furthermore, KIT tyrosine activity inhibition reduced 3BP2 and MITF expression, demonstrating again a tight and reciprocal relationship between these molecules. Taken together, our results show that 3BP2 regulates huMC survival and participates in KIT-mediated signal transduction by directly controlling KIT receptor expression, suggesting its potential as a therapeutic target in mast cell\u2013mediated inflammatory diseases and deregulated KIT disorders.<\/jats:p>","DOI":"10.4049\/jimmunol.1402887","type":"journal-article","created":{"date-parts":[[2015,3,26]],"date-time":"2015-03-26T10:07:42Z","timestamp":1427364462000},"page":"4309-4318","source":"Crossref","is-referenced-by-count":24,"title":["The Adaptor 3BP2 Is Required for KIT Receptor Expression and Human Mast Cell Survival"],"prefix":"10.1093","volume":"194","author":[{"given":"Erola","family":"Ainsua-Enrich","sequence":"first","affiliation":[{"name":"Biochemistry Unit, Faculty of Medicine, University of Barcelona , 08036 Barcelona ,","place":["Spain"]},{"name":"Laboratori d'Immunoall\u00e8rgia Respirat\u00f2ria Cl\u00ednica i Experimental, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer , 08036 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Serrano-Candelas","sequence":"additional","affiliation":[{"name":"Biochemistry Unit, Faculty of Medicine, University of Barcelona , 08036 Barcelona ,","place":["Spain"]},{"name":"Laboratori d'Immunoall\u00e8rgia Respirat\u00f2ria Cl\u00ednica i Experimental, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer , 08036 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiana","family":"\u00c1lvarez-Errico","sequence":"additional","affiliation":[{"name":"Biochemistry Unit, Faculty of Medicine, University of Barcelona , 08036 Barcelona ,","place":["Spain"]},{"name":"Laboratori d'Immunoall\u00e8rgia Respirat\u00f2ria Cl\u00ednica i Experimental, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer , 08036 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Picado","sequence":"additional","affiliation":[{"name":"Laboratori d'Immunoall\u00e8rgia Respirat\u00f2ria Cl\u00ednica i Experimental, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer , 08036 Barcelona ,","place":["Spain"]},{"name":"Networking Research Center on Respiratory Diseases, Institute of Health Carlos III , 28029 Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Say\u00f3s","sequence":"additional","affiliation":[{"name":"Immunobiology Group, Molecular Biology and Biochemistry Research Center for Nanomedicine, Nanomedicine Program, Vall d\u2019Hebr\u00f3n Research Institute, Autonomous University of Barcelona , 08035 Barcelona ,","place":["Spain"]},{"name":"Networking Research Center on Bioengineering, Biomaterials and Nanomedicine, Institute of Health Carlos III , 28029 Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Rivera","sequence":"additional","affiliation":[{"name":"Molecular Immunology Section, Laboratory of Molecular Immunogenetics, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Mart\u00edn","sequence":"additional","affiliation":[{"name":"Biochemistry Unit, Faculty of Medicine, University of Barcelona , 08036 Barcelona ,","place":["Spain"]},{"name":"Laboratori d'Immunoall\u00e8rgia Respirat\u00f2ria Cl\u00ednica i Experimental, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer , 08036 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,5,1]]},"reference":[{"key":"2025030706154174700_r1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.21.120601.141025","article-title":"Mast cells as \u201ctunable\u201d effector and immunoregulatory cells: recent advances","volume":"23","author":"Galli","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"2025030706154174700_r2","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nri2327","article-title":"Immunomodulatory mast cells: negative, as well as positive, regulators of immunity","volume":"8","author":"Galli","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"2025030706154174700_r3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000236955","article-title":"The role of c-Kit and its ligand, stem cell factor, in mast cell apoptosis","volume":"107","author":"Mekori","year":"1995","journal-title":"Int. Arch. Allergy Immunol."},{"key":"2025030706154174700_r4","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s00018-004-4189-6","article-title":"Signal transduction via the stem cell factor receptor\/c-Kit","volume":"61","author":"R\u00f6nnstrand","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"2025030706154174700_r5","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1152\/physrev.00046.2011","article-title":"Stem cell factor receptor\/c-Kit: from basic science to clinical implications","volume":"92","author":"Lennartsson","year":"2012","journal-title":"Physiol. Rev."},{"key":"2025030706154174700_r6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nri1782","article-title":"Integrated signalling pathways for mast-cell activation","volume":"6","author":"Gilfillan","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"2025030706154174700_r7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/ejh.12043","article-title":"Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression","volume":"90","author":"Verstovsek","year":"2013","journal-title":"Eur. J. Haematol."},{"key":"2025030706154174700_r8","first-page":"351","article-title":"Adjuvant treatment of GIST: patient selection and treatment strategies. Nature reviews","volume":"9","author":"Joensuu","year":"2012","journal-title":"Clin. Oncol."},{"key":"2025030706154174700_r9","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.8438166","article-title":"Identification of a ten-amino acid proline-rich SH3 binding site","volume":"259","author":"Ren","year":"1993","journal-title":"Science"},{"key":"2025030706154174700_r10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2174\/092986708783769795","article-title":"Adaptor protein 3BP2 and cherubism","volume":"15","author":"Hatani","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"2025030706154174700_r11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cell.2006.10.047","article-title":"Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 \u201ccherubism\u201d mice","volume":"128","author":"Ueki","year":"2007","journal-title":"Cell"},{"key":"2025030706154174700_r12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/0-387-34132-3_8","article-title":"The adapter 3BP2: how it plugs into leukocyte signaling","volume":"584","author":"Deckert","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"key":"2025030706154174700_r13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1074-7613(00)80657-3","article-title":"Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activation","volume":"9","author":"Deckert","year":"1998","journal-title":"Immunity"},{"key":"2025030706154174700_r14","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1182\/blood-2003-08-2965","article-title":"The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor","volume":"105","author":"Foucault","year":"2005","journal-title":"Blood"},{"key":"2025030706154174700_r15","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1128\/MCB.01014-06","article-title":"The 3BP2 adapter protein is required for optimal B-cell activation and thymus-independent type 2 humoral response","volume":"27","author":"Chen","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"2025030706154174700_r16","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1128\/MCB.00087-06","article-title":"3BP2 deficiency impairs the response of B cells, but not T cells, to antigen receptor ligation","volume":"26","author":"de la Fuente","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"2025030706154174700_r17","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.4049\/jimmunol.166.12.7219","article-title":"Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2","volume":"166","author":"Jevremovic","year":"2001","journal-title":"J. Immunol."},{"key":"2025030706154174700_r18","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.4049\/jimmunol.1200380","article-title":"The adaptor 3BP2 is required for early and late events in Fc\u03b5RI signaling in human mast cells","volume":"189","author":"Ainsua-Enrich","year":"2012","journal-title":"J. Immunol."},{"key":"2025030706154174700_r19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0145-2126(02)00343-0","article-title":"Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma\/leukemia; activation following aggregation of Fc\u03b5RI or Fc\u03b3RI","volume":"27","author":"Kirshenbaum","year":"2003","journal-title":"Leuk. Res."},{"key":"2025030706154174700_r20","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im0737s90","article-title":"Generation, isolation, and maintenance of human mast cells and mast cell lines derived from peripheral blood or cord blood","volume-title":"Curr. Protoc. Immunol.","author":"Radinger","year":"2010"},{"key":"2025030706154174700_r21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-3083.1994.tb03404.x","article-title":"Phenotypic characterization of the human mast-cell line HMC-1","volume":"39","author":"Nilsson","year":"1994","journal-title":"Scand. J. Immunol."},{"key":"2025030706154174700_r22","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212\u0394\u0394C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"2025030706154174700_r23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0022-1759(02)00210-7","article-title":"Determination of protein phosphorylation in Fc\u03b5RI-activated human mast cells by immunoblot analysis requires protein extraction under denaturing conditions","volume":"268","author":"Tkaczyk","year":"2002","journal-title":"J. Immunol. Methods"},{"key":"2025030706154174700_r24","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.4049\/jimmunol.1101626","article-title":"CD84 negatively regulates IgE high-affinity receptor signaling in human mast cells","volume":"187","author":"\u00c1lvarez-Errico","year":"2011","journal-title":"J. Immunol."},{"key":"2025030706154174700_r25","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1182\/blood.V97.12.3867","article-title":"Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP","volume":"97","author":"Say\u00f3s","year":"2001","journal-title":"Blood"},{"key":"2025030706154174700_r26","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.4049\/jimmunol.175.7.4226","article-title":"The adaptor protein 3BP2 binds human CD244 and links this receptor to Vav signaling, ERK activation, and NK cell killing","volume":"175","author":"Saborit-Villarroya","year":"2005","journal-title":"J. Immunol."},{"key":"2025030706154174700_r27","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.4049\/jimmunol.174.10.5977","article-title":"Identification of Grb2 as a novel binding partner of the signaling lymphocytic activation molecule-associated protein binding receptor CD229","volume":"174","author":"Mart\u00edn","year":"2005","journal-title":"J. Immunol."},{"key":"2025030706154174700_r28","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood-2004-02-0631","article-title":"Kit and Fc\u03b5RI mediate unique and convergent signals for release of inflammatory mediators from human mast cells","volume":"104","author":"Hundley","year":"2004","journal-title":"Blood"},{"key":"2025030706154174700_r29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0145-2126(88)90050-1","article-title":"Establishment of an immature mast cell line from a patient with mast cell leukemia","volume":"12","author":"Butterfield","year":"1988","journal-title":"Leuk. Res."},{"key":"2025030706154174700_r30","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","article-title":"Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product","volume":"92","author":"Furitsu","year":"1993","journal-title":"J. Clin. Invest."},{"key":"2025030706154174700_r31","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V85.3.790.bloodjournal853790","article-title":"Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines","volume":"85","author":"Kitayama","year":"1995","journal-title":"Blood"},{"key":"2025030706154174700_r32","doi-asserted-by":"crossref","first-page":"11039","DOI":"10.1074\/jbc.M808058200","article-title":"The D816V mutation of c-Kit circumvents a requirement for Src family kinases in c-Kit signal transduction","volume":"284","author":"Sun","year":"2009","journal-title":"J. Biol. Chem."},{"key":"2025030706154174700_r33","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0960-9822(98)70302-1","article-title":"The kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136","volume":"8","author":"Blume-Jensen","year":"1998","journal-title":"Curr. Biol."},{"key":"2025030706154174700_r34","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1349-7006.1993.tb02813.x","article-title":"Characterization of the promoter region of the human c-kit proto-oncogene","volume":"84","author":"Yamamoto","year":"1993","journal-title":"Jpn. J. Cancer Res."},{"key":"2025030706154174700_r35","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.4049\/jimmunol.1001228","article-title":"GATA2 and Sp1 positively regulate the c-kit promoter in mast cells","volume":"185","author":"Maeda","year":"2010","journal-title":"J. Immunol."},{"key":"2025030706154174700_r36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)80240-8","article-title":"The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells","volume":"89","author":"Zheng","year":"1997","journal-title":"Cell"},{"key":"2025030706154174700_r37","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/ni1486","article-title":"Mast cell lineage diversion of T lineage precursors by the essential T cell transcription factor GATA-3","volume":"8","author":"Taghon","year":"2007","journal-title":"Nat. Immunol."},{"key":"2025030706154174700_r38","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1084\/jem.188.3.439","article-title":"Transcription factor SCL is required for c-kit expression and c-Kit function in hemopoietic cells","volume":"188","author":"Krosl","year":"1998","journal-title":"J. Exp. Med."},{"key":"2025030706154174700_r39","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood.V88.4.1225.bloodjournal8841225","article-title":"Involvement of transcription factor encoded by the mi locus in the expression of c-kit receptor tyrosine kinase in cultured mast cells of mice","volume":"88","author":"Tsujimura","year":"1996","journal-title":"Blood"},{"key":"2025030706154174700_r40","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1242\/dev.124.12.2377","article-title":"Melanocyte development in vivo and in neural crest cell cultures: crucial dependence on the Mitf basic-helix-loop-helix-zipper transcription factor","volume":"124","author":"Opdecamp","year":"1997","journal-title":"Development"},{"key":"2025030706154174700_r41","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1182\/blood-2010-07-293548","article-title":"KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation","volume":"117","author":"Lee","year":"2011","journal-title":"Blood"},{"key":"2025030706154174700_r42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/imr.12042","article-title":"The role of miRNAs in mast cells and other innate immune cells","volume":"253","author":"Montagner","year":"2013","journal-title":"Immunol. Rev."},{"key":"2025030706154174700_r43","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/onc.2010.536","article-title":"A variant in a MicroRNA complementary site in the 3\u2032 UTR of the KIT oncogene increases risk of acral melanoma","volume":"30","author":"Godshalk","year":"2011","journal-title":"Oncogene"},{"key":"2025030706154174700_r44","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1158\/0008-5472.CAN-09-1449","article-title":"Proapoptotic activity of bortezomib in gastrointestinal stromal tumor cells","volume":"70","author":"Bauer","year":"2010","journal-title":"Cancer Res."},{"key":"2025030706154174700_r45","doi-asserted-by":"crossref","first-page":"e26133","DOI":"10.1371\/journal.pone.0026133","article-title":"MiR-221 influences effector functions and actin cytoskeleton in mast cells","volume":"6","author":"Mayoral","year":"2011","journal-title":"PLoS One"},{"key":"2025030706154174700_r46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/IR:34:2:97","article-title":"Development, migration, and survival of mast cells","volume":"34","author":"Okayama","year":"2006","journal-title":"Immunol. Res."},{"key":"2025030706154174700_r47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1042\/BJ20060464","article-title":"Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor\/c-Kit is required for ligand-induced ubiquitination, internalization and degradation","volume":"399","author":"Masson","year":"2006","journal-title":"Biochem. J."},{"key":"2025030706154174700_r48","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1016\/j.molimm.2008.03.021","article-title":"The adaptor 3BP2 activates CD244-mediated cytotoxicity in PKC- and SAP-dependent mechanisms","volume":"45","author":"Saborit-Villarroya","year":"2008","journal-title":"Mol. Immunol."},{"key":"2025030706154174700_r49","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","article-title":"Mast cells and mastocytosis","volume":"112","author":"Metcalfe","year":"2008","journal-title":"Blood"},{"key":"2025030706154174700_r50","first-page":"1115","article-title":"Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant","volume":"1","author":"Frost","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"2025030706154174700_r51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/13543784.2013.740010","article-title":"Therapeutic targeting of c-KIT in cancer","volume":"22","author":"Ashman","year":"2013","journal-title":"Expert Opin. Investig. Drugs"},{"key":"2025030706154174700_r52","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.bone.2003.08.014","article-title":"Mitf and Tfe3: members of a b-HLH-ZIP transcription factor family essential for osteoclast development and function","volume":"34","author":"Hershey","year":"2004","journal-title":"Bone"},{"key":"2025030706154174700_r53","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1172\/JCI45843","article-title":"3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions","volume":"121","author":"Levaot","year":"2011","journal-title":"J. Clin. Invest."},{"key":"2025030706154174700_r54","doi-asserted-by":"crossref","first-page":"20952","DOI":"10.1074\/jbc.M109.091124","article-title":"3BP2 adapter protein is required for receptor activator of NF\u03baB ligand (RANKL)-induced osteoclast differentiation of RAW264.7 cells","volume":"285","author":"GuezGuez","year":"2010","journal-title":"J. Biol. Chem."},{"key":"2025030706154174700_r55","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S1097-2765(01)00360-4","article-title":"Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi\/mi) mice","volume":"8","author":"Weilbaecher","year":"2001","journal-title":"Mol. Cell"},{"key":"2025030706154174700_r56","doi-asserted-by":"crossref","first-page":"11077","DOI":"10.1074\/jbc.M111696200","article-title":"Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-\u03baB ligand signaling","volume":"277","author":"Mansky","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2025030706154174700_r57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/88832","article-title":"Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism","volume":"28","author":"Ueki","year":"2001","journal-title":"Nat. Genet."},{"key":"2025030706154174700_r58","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cell.2011.10.045","article-title":"Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism","volume":"147","author":"Levaot","year":"2011","journal-title":"Cell"},{"key":"2025030706154174700_r59","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.cell.2011.10.046","article-title":"Structural basis and sequence rules for substrate recognition by Tankyrase explain the basis for cherubism disease","volume":"147","author":"Guettler","year":"2011","journal-title":"Cell"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/194\/9\/4309\/61564961\/1402887.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/194\/9\/4309\/61564961\/1402887.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T07:20:01Z","timestamp":1741332001000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/194\/9\/4309\/7973089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,1]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,5,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1402887","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,5]]},"published":{"date-parts":[[2015,5,1]]}}}